Based on the above results, we conclude that TRPS1 is positively associated with E-cadherin and β-catenin status in ERα-positive breast cancer, while it also has a significant association with mesenchymal markers of EMT in ERα-negative breast cancer. Here, TRPS1 is linked to breast carcinoma.